share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs John C

SEC announcement ·  Jan 25 17:08
Summary by Moomoo AI
On January 23, 2024, John C. Jacobs, President and CEO of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. Jacobs exercised options to acquire 83,197 shares. On the same day, he sold 40,093 shares at a price of $4.26 per share, resulting in a total market value of $170,796.18 for the disposed shares. Following these transactions, Jacobs's direct holdings in Novavax common stock amounted to 43,104 shares.
On January 23, 2024, John C. Jacobs, President and CEO of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. Jacobs exercised options to acquire 83,197 shares. On the same day, he sold 40,093 shares at a price of $4.26 per share, resulting in a total market value of $170,796.18 for the disposed shares. Following these transactions, Jacobs's direct holdings in Novavax common stock amounted to 43,104 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more